The Pirbright Institute and its research partners have granted MSD Animal Health an exclusive commercial licence for a new, effective and affordable vaccine to protect livestock against several serotypes of foot-and-mouth disease virus (FMDV).

The remaining restrictions on livestock imposed in the wake of the foot-and-mouth outbreak in the UK will be lifted today after experts declared the disease had been eradicated.